Research Group Lung Cancer

  • Visiting address


Unit profile


Lung cancer, the leading cause of cancer death, is divided into histological subtypes with large differences in molecular alterations, clinical presentation, and patient outcome. By a combined clinical and molecular approach we focus on improving the molecular understanding of lung cancer and translate research findings into a clinical diagnostics. By characterization of the genomic, transcriptional, and DNA methylation landscape in different lung cancer subgroups in both own and public cohorts we search for new molecular subgroups of potential clinical relevance, additional targets for synergistic treatment, prognostic and/or predictive markers of relapse or response to therapy, and a deepened understanding of the molecular pathogenesis. By analysis of patient specific alterations in circulating tumor DNA in blood samples we aim to establish blood-based assays for early detection of lung cancer, treatment monitoring, and early detection of relapse in the primary and advanced setting.

UKÄ subject classification

  • Cancer and Oncology

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or